Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2024 Earnings Conference Call July 18, 2024 4:30 PM ET
Company Participants
Brian King - Head of IR
Gary Guthart - CEO
Dave Rosa - President
Jamie Samath - CFO
Conference Call Participants
Larry Biegelsen - Wells Fargo
Travis Steed - Bank of America
Robbie Marcus - JPMorgan
David Roman - Goldman Sachs
Rick Wise - Stifel
Drew Ranieri - Morgan Stanley
Adam Maeder - Piper Sandler
Richard Newitter - Truist Securities
Operator
Thank you everyone for standing by and welcome to the Intuitive Second Quarter 2024 Earnings Release. [Operator Instructions] As a reminder, today's call is being recorded.
I will now turn the call over to your host, Head of Investor Relations, Brian King. Please go ahead.
Brian King
Good afternoon and welcome to Intuitive second quarter earnings conference call. With me today we have Gary Guthart, our CEO; Dave Rosa, our President; and Jamie Samath, our CFO.
Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K for the fiscal year ended December 31, 2023 and subsequent filings. Our SEC filings can be found through our website or at the SEC's website.
Investors are cautioned not to place undue reliance on such forward-looking statements. Please note that this conference call will be available for audio replay on our website at intuitive.com, on the Events section under our Investor Relations page. Today's press release and supplementary financial data tables have been posted to our website.
Today's format will consist of providing you with highlights of our second quarter results, as described in our press release announced earlier today, followed by a question-and-answer session. Gary will introduce the call and provide an organization update. Dave will present the quarter's business and operational highlights. Jamie will provide a review of our financial results. Then I will discuss procedure and clinical highlights and provide our updated financial outlook for 2024. And finally, we will host a question-and-answer session.
With that, I will turn it over to Gary.
Gary Guthart
Thank you for joining us today.
The fundamentals of our business were healthy in the quarter, with solid procedure growth and strong capital placements resulting in healthy financial performance. In the quarter, we made good progress with all three of our system platforms, including taking our measured rollout of da Vinci 5 to our next phase, continuing to stabilize Ion supply in support of customer expansion and expanding da Vinci SP installs in Europe, while supporting SP procedure growth across regions. Some multi-port procedure headwinds continued from last quarter and we will describe these later on the call.